1- Comité Français de Lutte contre l'hypertension Artérielle (CFLHTA). Enquête FLAHS 2010 (French League Against Hypertension Survey [FLAHS]). Les traitements par les antihypertenseurs en France en 2010 ?
3- Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of Hypertension 2009; 27:2121-2158.
4- The NAVIGATOR Study Group. Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. N Engl J Med 2010;362:1477-90.
6- Godet-Mardirossian H, Girerd X, Vernay M, Chamontin M, Katia Castetbon K, de Peretti C. Patterns of hypertension management in France (ENNS 2006–2007). Eur J Cardiovasc Prev Rehabil. 2011 Mar 30. [Epub ahead of print]
7- Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol. 2011;57(5):590-600.
8- Myers MG, Godwin M, Dawes M, Kiss A et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ 2011;342:d286; doi:10.1136/bmj.d286
10- The ACCORD Study Group. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 2010;362:1575-85.
Mise au point
Palpitations : orientation diagnostique
En 5 points
Obésité : suivi d’un patient sous aGLP-1
Cas clinique
La fasciite nécrosante
Mise au point
La périménopause